These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7438770)

  • 1. Spironolactone in the long-term management of patients with congestive heart failure.
    Smith AG
    Curr Med Res Opin; 1980; 7(2):131-6. PubMed ID: 7438770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and safety of furosemide and a combination of spironolactone and hydrochlorothiazide in congestive heart failure.
    Levy B
    J Clin Pharmacol; 1977 Jul; 17(7):420-30. PubMed ID: 328540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of spironolactone on serum and muscle electrolytes in patients on long-term diuretic therapy for congestive heart failure and/or arterial hypertension.
    Dyckner T; Wester PO; Widman L
    Eur J Clin Pharmacol; 1986; 30(5):535-40. PubMed ID: 3758141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective double-blind randomized placebo-controlled clinical trial to evaluate the safety and efficacy of spironolactone in patients with advanced congestive heart failure on continuous ambulatory peritoneal dialysis.
    Taheri S; Mortazavi M; Pourmoghadas A; Seyrafian S; Alipour Z; Karimi S
    Saudi J Kidney Dis Transpl; 2012 May; 23(3):507-12. PubMed ID: 22569436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of non-digitalized congestive heart failure patients with a fixed-dose combination of furosemide and spironolactone.
    Yasky J; Ledesma GA; Tutera A; Collia LF
    Pharmatherapeutica; 1986; 4(8):480-5. PubMed ID: 3714756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long term therapy over nine years with Spironolacton in hydropic cardiac insufficiency].
    Ehrlich U; Klepzig H
    Med Klin; 1976 Sep; 71(38):1546-54. PubMed ID: 135920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]).
    Am J Cardiol; 1996 Oct; 78(8):902-7. PubMed ID: 8888663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of the therapeutic efficacy of spironolactone and furosemide in patients with severe congestive heart failure].
    Bednarz B; Cybulski J; Chamiec T
    Pol Merkur Lekarski; 2000 Aug; 9(50):519-21. PubMed ID: 11081314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of 2 diuretic-containing combination preparations in patients with edematous heart failure].
    Mauersberger H; Rangoonwala B; Ehrlich E
    Wien Med Wochenschr; 1985 Apr; 135(8):205-13. PubMed ID: 4013351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spironolactone in the management of congestive heart failure.
    Muller JE
    Am J Cardiol; 1990 Jun; 65(23):51K-53K. PubMed ID: 2353671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fixed-dose combination of furosemide and spironolactone in digitalized congestive heart failure patients.
    Yasky J; Ledesma GA; Tutera A; Collia LF
    Pharmatherapeutica; 1986; 4(8):473-9. PubMed ID: 3714755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcardiac gradient of aldosterone before and after spironolactone in patients with congestive heart failure.
    Tsutamoto T; Wada A; Maeda K; Hayashi M; Tsutsui T; Ohnishi M; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Ishii C
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S19-22. PubMed ID: 12688391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diuretic therapy in congestive heart failure--new views on spironolactone therapy].
    Haller C
    Ther Umsch; 2000 Jun; 57(6):374-9. PubMed ID: 10894022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spironolactone in the treatment of congestive heart failure.
    Lloyd SJ; Mauro VF
    Ann Pharmacother; 2000 Nov; 34(11):1336-40. PubMed ID: 11098350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spot urine sodium excretion as prognostic marker in acutely decompensated heart failure: the spironolactone effect.
    Ferreira JP; Girerd N; Medeiros PB; Santos M; Carvalho HC; Bettencourt P; Kénizou D; Butler J; Zannad F; Rossignol P
    Clin Res Cardiol; 2016 Jun; 105(6):489-507. PubMed ID: 26615605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spironolactone therapy in infants with congestive heart failure secondary to congenital heart disease.
    Hobbins SM; Fowler RS; Rowe RD; Korey AG
    Arch Dis Child; 1981 Dec; 56(12):934-8. PubMed ID: 7036914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of spironolactone on ventricular arrhythmias in congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy.
    Ramires FJ; Mansur A; Coelho O; Maranhão M; Gruppi CJ; Mady C; Ramires JA
    Am J Cardiol; 2000 May; 85(10):1207-11. PubMed ID: 10802002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure.
    Shah KB; Rao K; Sawyer R; Gottlieb SS
    J Am Coll Cardiol; 2005 Sep; 46(5):845-9. PubMed ID: 16139135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Life-threatening hyperkalemia: a complication of spironolactone for heart failure in a patient with renal insufficiency.
    Hu Y; Carpenter JP; Cheung AT
    Anesth Analg; 2002 Jul; 95(1):39-41, table of contents. PubMed ID: 12088939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease.
    Barr CS; Lang CC; Hanson J; Arnott M; Kennedy N; Struthers AD
    Am J Cardiol; 1995 Dec; 76(17):1259-65. PubMed ID: 7503007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.